Core Viewpoint - Medicure Technology (02158) has been actively repurchasing its shares, indicating confidence in its stock value and future prospects [1] Share Buyback Activity - On October 14, Medicure Technology repurchased 1.4728 million shares at a price range of HKD 5.75 to HKD 5.99, totaling HKD 8.58 million [1] - Since September 26, the company has conducted four share buybacks, accumulating a total of 3.1916 million shares repurchased, with a total expenditure of HKD 18.6359 million [1] Product Development and Market Support - The company has provided critical market research and project analysis services for the recently approved topical treatment for infantile hemangiomas, marking a significant advancement in its product offerings [1]